SbD4Nano (2020–2024) involved AMBROSIALAB in building computing infrastructure for defining and performance-testing safe-by-design approaches for nanomaterials.
AMBROSIALAB SRL
Italian SME bridging nanomaterial safety informatics and bio-based nanocomposite development for packaging, textile, and automotive industries.
Their core work
AMBROSIALAB is an Italian technology SME based in Ferrara specializing in nanomaterial safety science and bio-based polymer nanocomposites. Their work sits at the intersection of computational nanosafety and applied materials science: they contribute nano-informatics tools and exposure assessment methods to evaluate whether nanomaterials are safe by design before they reach industrial production. In parallel, they work on developing and testing nano-enabled bio-based materials — bionanocomposites intended for real industrial end-uses such as packaging, textiles, and automotive parts. Their dual competence in safety assessment methodology and material application testing makes them a specialist partner in EU projects that need both regulatory credibility and industrial relevance.
What they specialise in
SbD4Nano keywords include nano-informatics, data-sharing, and exposure — indicating a computational and data-driven approach to nanomaterial risk characterisation.
BIONANOPOLYS (2021–2024) focused on developing safe nano-enabled bio-based materials and polymer bionanocomposites within an open innovation test bed framework.
BIONANOPOLYS targeted packaging, textile, non-woven, and automotive sectors as end-use application areas for nano-enabled bio-based materials.
Both projects involve open-access infrastructure elements — data-sharing platforms in SbD4Nano and an open innovation test bed in BIONANOPOLYS.
How they've shifted over time
AMBROSIALAB entered H2020 with a clear computational nanosafety focus — their first project centred on nano-informatics, exposure modelling, and safe-by-design frameworks, suggesting a background in regulatory science or computational chemistry. Their second project shifted toward the materials side of the same domain: instead of assessing whether nanomaterials are safe, they moved into actually producing bio-based nanocomposites and testing them for industrial markets like packaging and automotive. The trajectory is a natural maturation — from safety tools and methodology toward applying those safety principles in real material development — positioning them as a bridge between nanosafety compliance and industrial material innovation.
AMBROSIALAB appears to be moving from pure safety assessment methodology toward applied material development, making them an increasingly relevant partner for industrial actors who need both compliant and market-ready nano-enabled materials.
How they like to work
AMBROSIALAB has participated exclusively as a consortium partner, never as project coordinator — a pattern consistent with a specialist SME that brings specific technical capabilities to large multi-partner projects rather than initiating and managing them. Both their projects are large European consortia (one RIA, one IA), meaning they are accustomed to working within complex, multi-institutional environments with clearly defined task contributions. Their 48 unique partners across 15 countries from just two projects indicates they have joined well-networked, pan-European initiatives, broadening their contact base significantly relative to their size.
Despite having only two projects, AMBROSIALAB has connected with 48 unique partners across 15 countries — an unusually broad network for a micro-SME, reflecting their participation in large, internationally diverse consortia. Their network spans primarily European partners, consistent with the H2020 programme's geographic spread.
What sets them apart
AMBROSIALAB occupies a rare niche: an SME that combines computational nanosafety expertise (nano-informatics, exposure modelling, safe-by-design frameworks) with hands-on bio-based material development and testing. Most nanosafety actors are either academic groups running models or industrial labs focused on production — AMBROSIALAB appears to bridge both. For consortium builders, they offer the credibility of a dedicated safety-science partner alongside practical industrial application experience in packaging, textile, and automotive materials, making them particularly valuable in projects that must satisfy both regulatory and market requirements.
Highlights from their portfolio
- BIONANOPOLYSLargest project by EC contribution (€128,398) and broadest industrial scope — simultaneously targeting packaging, textile, non-woven, and automotive sectors under an open innovation test bed model, demonstrating AMBROSIALAB's ability to contribute to multi-market material development.
- SbD4NanoSignals AMBROSIALAB's foundational competence in computational nanosafety infrastructure, a high-priority regulatory area as EU chemicals legislation tightens around engineered nanomaterials.